The historical rank and industry rank for ARS Pharmaceuticals's Pretax Margin % or its related term are showing as below:
SPRY'
s Pretax Margin % Range Over the Past 10 Years
Min: -496960 Med: -1501.53 Max: -5.97
Current: -496960
SPRY's Pretax Margin % is ranked worse than 99.13% of 1033
companies
in the Biotechnology industry
Industry Median: -172.84
vs SPRY: -496960.00
ARS Pharmaceuticals Pretax Margin % Historical Data
The historical data trend for ARS Pharmaceuticals's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of ARS Pharmaceuticals's Pretax Margin %
For the Biotechnology subindustry, ARS Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ARS Pharmaceuticals's Pretax Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, ARS Pharmaceuticals's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where ARS Pharmaceuticals's Pretax Margin % falls into.
ARS Pharmaceuticals Pretax Margin % Calculation
Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.
ARS Pharmaceuticals's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ARS Pharmaceuticals (NAS:SPRY) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
ARS Pharmaceuticals Pretax Margin % Related Terms
Thank you for viewing the detailed overview of ARS Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
ARS Pharmaceuticals (ARS Pharmaceuticals) Business Description
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy (previously referred to as ARS-1) for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SPRY has been successfully added to your 